XML 56 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
                
   For the years ended December 31, 
(dollars in thousands)  2023   2022   2021 
Stock option expense  $528    927    1,148 
Restricted stock grant expense   1,415    1,099    499 
Total stock-based compensation expense  $1,943    2,026    1,647 
Schedule of the status of the stock option plan and changes
         
      
   For the years ended December 31,  
   2023    2022    2021   
   Shares   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life
    Shares   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life
    Shares   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life
 
Outstanding at beginning of year   427,224   $34.32         464,724   $33.97         495,195   $29.93      
Granted   -    -         -    -         121,000    40.45      
Exercised   (27,250)   20.18         (32,375)   27.94         (127,871)   23.56      
Forfeited or expired   (68,625)   34.15         (5,125)   43.14         (23,600)   38.88      
Outstanding at end of year   331,349   $35.51   4.9 years     427,224   $34.32   5.7 years     464,724   $33.97   6.6 years  
Options exercisable at year-end   267,376   $34.48   4.5 years     287,902   $32.35   4.8 years     239,340   $29.68   5.0 years  
Weighted average fair value of options granted during the year       $-             $-             $16.40      
Shares available for grant   319,058              370,824              422,550           
Schedule of assumptions used
              
   2023   2022   2021 
Dividend yield   -n/a    n/a    - 
Expected life   n/a    n/a    7 years 
Expected volatility   n/a    n/a    38.48%
Risk-free interest rate   n/a    n/a    0.74%
Schedule of the status of the company's nonvested restricted stock and changes
     
   December 31, 
   2023   2022   2021 
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
 
Nonvested at beginning of year   80,337   $52.53    41,699   $44.71    26,099   $38.05 
Granted   69,880    37.12    53,376    56.25    26,450    48.56 
Vested   (21,695)   48.95    (14,213)   43.26    (9,600)   38.03 
Forfeited   (18,989)   46.83    (525)   61.14    (1,250)   38.56 
Nonvested at end of year   109,533   $44.40    80,337   $52.53    41,699   $44.71